Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

The Department of War (Defense Health Agency) is issuing an RFQ to obtain price quotes (UF BPA) and additional discount/refund quotes (UF ADP) for pharmaceutical agents that will be placed on the Uniform Formulary (UF) for the Military Health System. Manufacturers must submit separate quotes for each drug and NDC‑11 listed, include a signed UF BPA or UF ADP, and provide a clinical questionnaire response by the deadlines. The process includes a pre‑quotation teleconference (Sept 9 2026), a quote submission deadline (Sept 24 2026), and a P&T Committee review (Nov 4‑5 2026). Successful quotes may result in blanket purchase agreements covering Military Treatment Facilities, TRICARE Mail Order Pharmacy, and the TRICARE retail network, with pricing valid for at least 180 days and subject to annual price‑adjustment limits. • Solicitation ID: HT9402‑26‑Q‑9403 (RFQ) • Target audience: pharmaceutical manufacturers with FDA‑approved, self‑administered outpatient drugs. • Key deadlines: Pre‑quotation teleconference 9 Sept 2026; Clinical questions 24 Sept 2026; Quote submission 24 Sept 2026; P&T Committee meeting 4‑5 Nov 2026. • Required deliverables: UF BPA price quote, UF ADP refund quote, NDC price list, signed checklists, SAM registration, TAA compliance certification. • Contract scope: pricing for MTFs, TRICARE mail‑order, and retail pharmacy network; refunds based on utilization; agreement terminates upon re‑evaluation of the drug class or by notice.